GERALD
JEFFCOTT,
3Sixty Public Affairs
(Consultant)
Learn more...
Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.
Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.
Results below are sorted by posted date, beginning with the most recent.
-
RAREi - The Canadian Forum for Rare Disease Innovators
Consultant:
GERALD JEFFCOTT
Designated Public Office Holders who participated in the communication:
-
Daniel MacDonald,
Director General
| Drugs for Rare Diseases
|
Health Canada (HC)
Subject Matter of the communication:
Health,
Industry,
Budget
Communication date:
2024-10-24
Posted date:
2024-11-04
Communication number:
368917-619755
View monthly communication report
-
RAREi - The Canadian Forum for Rare Disease Innovators
Consultant:
GERALD JEFFCOTT
Designated Public Office Holders who participated in the communication:
-
Guillaume Couillard,
Director General
|
Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication:
Industry
Communication date:
2024-08-08
Posted date:
2024-09-10
Communication number:
368917-614092
View monthly communication report
-
RAREi - The Canadian Forum for Rare Disease Innovators
Consultant:
GERALD JEFFCOTT
Designated Public Office Holders who participated in the communication:
-
Daniel MacDonald,
Director General
| Drugs for Rare Diseases
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2023-12-04
Posted date:
2024-01-02
Communication number:
368917-589568
View monthly communication report
-
RAREi - The Canadian Forum for Rare Disease Innovators
Consultant:
GERALD JEFFCOTT
Designated Public Office Holders who participated in the communication:
-
Guillaume Coulliard,
Executive Director (acting)
| Patented Medicine Prices Review Board
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2023-10-06
Posted date:
2023-11-02
Communication number:
368917-581001
View monthly communication report
-
RAREi - The Canadian Forum for Rare Disease Innovators
Consultant:
GERALD JEFFCOTT
Designated Public Office Holders who participated in the communication:
-
Douglas Clark,
Executive Director
|
Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication:
Health
Communication date:
2022-12-05
Posted date:
2022-12-09
Communication number:
368917-549535
View monthly communication report
-
RAREi - The Canadian Forum for Rare Disease Innovators
Consultant:
GERALD JEFFCOTT
Designated Public Office Holders who participated in the communication:
-
Michelle Mujoomdar,
Director, Specialty Pharmaceuticals
| Strategic Policy Branch
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2022-09-28
Posted date:
2022-10-12
Communication number:
368917-543146
View monthly communication report
-
RAREi - The Canadian Forum for Rare Disease Innovators
Consultant:
GERALD JEFFCOTT
Designated Public Office Holders who participated in the communication:
-
Tanya Potashnik,
Director of Policy and Economic Analysis
|
Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication:
Health
Communication date:
2022-07-07
Posted date:
2022-08-04
Communication number:
368917-539124
View monthly communication report
-
RAREi - The Canadian Forum for Rare Disease Innovators
Consultant:
GERALD JEFFCOTT
Designated Public Office Holders who participated in the communication:
-
Sandenga Yeba,
Senior Policy Advisor
| Minister's Office
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2022-05-06
Posted date:
2022-06-07
Communication number:
368917-533436
View monthly communication report
-
RAREi - The Canadian Forum for Rare Disease Innovators
Consultant:
GERALD JEFFCOTT
Designated Public Office Holders who participated in the communication:
-
Brent Lawlor,
Director
| Office of Pharmaceuticals Management Strategies
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2022-01-14
Posted date:
2022-02-10
Communication number:
368917-521695
View monthly communication report
-
RAREi - The Canadian Forum for Rare Disease Innovators
Consultant:
GERALD JEFFCOTT
Designated Public Office Holders who participated in the communication:
-
Melissa Lantsman,
Member of Parliament (Thornhill)
|
House of Commons
Subject Matter of the communication:
Health,
Industry,
Science and Technology
Communication date:
2021-11-19
Posted date:
2022-06-07
Communication number:
368917-516569
View monthly communication report
-
RAREi - The Canadian Forum for Rare Disease Innovators
Consultant:
GERALD JEFFCOTT
Designated Public Office Holders who participated in the communication:
-
Kirsty Duncan,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2021-06-09
Posted date:
2021-07-05
Communication number:
368917-509597
View monthly communication report
-
RAREi - The Canadian Forum for Rare Disease Innovators
Consultant:
GERALD JEFFCOTT
Designated Public Office Holders who participated in the communication:
-
Earl Dreeshen,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2021-03-15
Posted date:
2021-04-08
Communication number:
368917-500899
View monthly communication report
-
RAREi - The Canadian Forum for Rare Disease Innovators
Consultant:
GERALD JEFFCOTT
Designated Public Office Holders who participated in the communication:
-
Majid Jowhari,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2021-03-15
Posted date:
2021-04-08
Communication number:
368917-500898
View monthly communication report
